Clinical Trial: Clinical Trial of the Use of Ketamine in Treatment Resistant Depression

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: Clinical Trial of the Use of Ketamine in Treatment Resistant Depression

Brief Summary: The purpose of this study is to determine the efficacy of the use of intravenous low-dose ketamine in the treatment of treatment-resistant depression (TRD), as well as the changes in Glutamate neurotransmission and inflammatory serum markers.